论文部分内容阅读
Phase Ⅰ safety and pharmacokinetic study of bevacizumab in Chinese patients with advanced cancer
【机 构】
:
Department of Medical Oncology,Beijing Hospital,Beijing 100730,China
【出 处】
:
第一届国家癌症中心学术年会
【发表日期】
:
2011年1期
其他文献
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a
会议
Smoking-attributable deaths and potential years of life lost from a large, representative study in C
Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: prel
Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, i